How to Prepare a 510(k) Submission When Your Device Includes Software

Submitting a 510(k) premarket notification for a device containing software requires a highly structured approach to regulatory compliance. With the FDA’s implementation of the Quality Management System Regulation (QMSR), which took effect on February 2, 2026 , the framework for medical device manufacturing has fundamentally shifted. 21 CFR Part 820 now incorporates by reference the international standard ISO 13485:2016. Navigating these requirements involves precise alignment of software validation, risk management, and cybersecurity controls. At MedLaunch, we turn these complicated regulatory requirements into clear, manageable steps. We guide you through the 510(k) process, ensuring your software-defined device is developed, approved, and launched on time and without unnecessary friction.

In this blog, we will cover the following key steps to simplify your software submission:

• Understanding when software complexity triggers additional regulatory scrutiny.
• Matching your software documentation to strict FDA expectations.
• Linking software safety to your device’s overall risk-benefit profile.
• Preventing common errors to avoid costly regulatory delays.

Determining When Software Triggers Additional Regulatory Scrutiny

The FDA evaluates software safety based on the device’s Documentation Level, which is categorized as either Basic or Enhanced. This categorization directly impacts the volume and granularity of evidence required in your premarket submission.

• Enhanced Documentation Level: This level applies if a failure or flaw of any device software function could present a hazardous situation with a probable risk of death or serious injury.
• Pre-Mitigation Assessment: This risk must be assessed prior to the implementation of risk control measures.
• High-Risk Categories: Enhanced documentation is also generally recommended for Class III devices and devices that are a constituent part of a combination product.
• Basic Documentation Level: This level applies to any premarket submission where the Enhanced Documentation criteria do not apply.

Integrating Software Risk Management Into Regulatory Strategy

Under the QMSR, manufacturers of class II and class III devices must comply with the requirements in Design and Development, Clause 7.3 and its Subclauses in ISO 13485. Your software development lifecycle must be strictly controlled and documented.

• Software Requirements Specification (SRS): Your submission must document the requirements for the software, including performance, interfaces, safety-related requirements derived from risk assessments, and intended operating environments.
• System and Software Architecture Diagram: You must provide detailed diagrams detailing the modules, layers, data flow, and interfaces that comprise the device.
• Software Verification and Validation: Software validation is a mandatory part of design validation. Submissions must include testing documentation at the unit, integration, and system levels.
• Traceability: The FDA expects clear processes to link user needs, software requirements, design specifications, testing, and implemented risk control measures. Unresolved Anomalies: You must provide a list of remaining unresolved software anomalies, complete with a risk-based rationale for not correcting the defect prior to release.

Aligning Software Documentation With FDA Submission Expectations

Regulators expect clear, organized, and comprehensive evidence that your software works exactly as intended. Aligning your technical files with FDA expectations is critical for a seamless review. You need to provide a complete Software Requirements Specification (SRS), detailed architecture design charts, and thorough verification and validation (V&V) test reports. Every line of code does not need to be submitted, but the FDA must see a clear narrative connecting your user needs to your testing outcomes. We provide the structured quality management support you need to organize these files perfectly, ensuring reviewers can easily navigate and approve your documentation.

Integrating Cybersecurity and Section 524B Requirements

Cybersecurity is an integral component of device safety and the QMSR. Section 524B of the FD&C Act mandates specific cybersecurity requirements for “cyber devices”. A cyber device is one that includes software, has the ability to connect to the internet, and contains technological characteristics that could be vulnerable to cybersecurity threats.

• Secure Product Development Framework (SPDF): Implementing an SPDF encompasses all aspects of a product’s lifecycle, including design, development, release, support, and decommission. It is utilized to identify and reduce vulnerabilities.
• Threat Modeling: Premarket submissions should include threat modeling documentation to demonstrate how the medical device system has been analyzed to identify potential security risks that could impact safety and effectiveness.
• Software Bill of Materials (SBOM): Section 524B(b)(3) of the FD&C Act requires manufacturers of cyber devices to provide an SBOM. This inventory must include commercial, open-source, and off-the-shelf software components.
• Cybersecurity Management Plan: You must submit a plan to monitor, identify, and address postmarket cybersecurity vulnerabilities and exploits in a reasonable time.

Addressing AI/ML Considerations

If your software incorporates artificial intelligence or machine learning (AI/ML), additional regulatory scrutiny applies. To provide an excellent 510(k) submission that addresses modern FDA expectations for AI/ML-enabled software, manufacturers should expand their documentation beyond basic model descriptions to include a total product lifecycle (TPLC) perspective. Based on current FDA guidance and the transition to the Quality Management System Regulation (QMSR), the AI/ML section should be expanded as follows:

• Model Description: Your software description must detail the methods, models, frameworks, and platforms used.
• Data Integrity: You must document the data populations used for training and the steps taken to identify and address potential biases and limitations of the models.
• Predetermined Change Control Plans (PCCP):  Under Section 515C of the FD&C Act, sponsors may propose a PCCP within their original 510(k) to pre-authorize future modifications.
• Human-AI Interaction & Clinical Workflow:  Documentation must explain how the AI output fits into the manual clinician or operator workflow including automation impact and workflow assumptions.
• Transparency: Your documentation must identify the materials, mechanisms, and approaches used to provide transparency about the model’s development, performance, and limitations.

Developing and launching a software-enabled medical device is hard enough, but your regulatory pathway does not have to be a barrier. A proactive, highly structured regulatory strategy dramatically reduces your time-to-market and minimizes compliance risks. By anticipating FDA expectations and organizing your documentation flawlessly, you accelerate your approval timeline. MedLaunch simplifies this entire process, offering you the strategic regulatory guidance needed to turn a complex 510(k) submission into a swift, successful market launch.